The goal of this study is to improve understanding of the immune regulatory mechanism in MTB infection, as well as enhance the development of potential PD-1/PD-L1 blockade to overcome the resistance mechanisms in TB disease, and to combat lung cancer. Here, CD274 is linked to lung carcinoma.